Page last updated: 2024-10-28

ha14-1 and Melanoma

ha14-1 has been researched along with Melanoma in 1 studies

ethyl 2-amino-6-bromo-4-(1-cyano-2-ethoxy-2-oxoethyl)-4H-chromene-3-carboxylate: a BH3 mimetic; synergistic induction of apoptosis by simultaneous disruption of the Bcl-2 and MEK/MAPK pathways in acute myelogenous leukemia

Melanoma: A malignant neoplasm derived from cells that are capable of forming melanin, which may occur in the skin of any part of the body, in the eye, or, rarely, in the mucous membranes of the genitalia, anus, oral cavity, or other sites. It occurs mostly in adults and may originate de novo or from a pigmented nevus or malignant lentigo. Melanomas frequently metastasize widely, and the regional lymph nodes, liver, lungs, and brain are likely to be involved. The incidence of malignant skin melanomas is rising rapidly in all parts of the world. (Stedman, 25th ed; from Rook et al., Textbook of Dermatology, 4th ed, p2445)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lickliter, JD1
Cox, J1
McCarron, J1
Martinez, NR1
Schmidt, CW1
Lin, H1
Nieda, M1
Nicol, AJ1

Other Studies

1 other study available for ha14-1 and Melanoma

ArticleYear
Small-molecule Bcl-2 inhibitors sensitise tumour cells to immune-mediated destruction.
    British journal of cancer, 2007, Feb-26, Volume: 96, Issue:4

    Topics: Adult; Antineoplastic Agents; Benzopyrans; Biphenyl Compounds; Cell Line, Tumor; Cell Proliferation;

2007
chemdatabank.com